These findings demonstrated that overexpression of LFA-1 in the CX3CL1/ICAM-1-mediated cycle could remarkably reverse the inhibition of CX3CR1 KD on NSCLC spinal metastasis. The gene discussed is ICAM1; the disease is non-small cell lung carcinoma.